Home > Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances.

European Monitoring Centre for Drugs and Drug Addiction. (2014) Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances. Luxembourg: Publications Office of the European Union.

[img] PDF (Report on the risk assessment of 4-methylamphetamine) - Published Version
773kB

This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the health and social risks posed by the substance, and, consequently, its control across the EU Member States.

Table of contents:
• Foreword
• Introduction
• EMCDDA actions on monitoring and responding to new drugs
• EMCDDA–Europol Joint Report on 4-methylamphetamine: a summary
• Risk Assessment Report of a new psychoactive substance: 4-methylamphetamine
• Annex 1: Technical report on 4-methylamphetamine
• Annex 2: Computational analysis on the pharmacology of 4-methylamphetamine
• Council Decision 2013/129/EU on subjecting 4-methylamphetamine to control measures
• Abbreviations
• Participants of the risk assessment meeting


Date:January 2014
Pages:59 p.
Publisher:Publications Office of the European Union
Corporate Creators:European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Luxembourg
ISBN:978-92-9168-601-8
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Substances > New (novel) psychoactive substances
B Substances > CNS stimulants > Amphetamines
VA Geographic area > Europe
A Substance use, abuse, and dependence > Effects and consequences

Repository Staff Only: item control page